All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results | 2005-001074-27 | A MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED, ASCENDING DOSE, CLINICAL TRIAL OF INTRA-VENOUS MICROPLASMIN ADMINISTRATION IN PATIENTS WITH ACUTE ISCHEMIC STROKE | 2008-05-05 | due-trials |
| Reported results Terminated | 2005-001075-35 | AN OPEN-LABEL CLINICAL TRIAL OF INTRA-ARTERIAL MICROPLASMIN ADMINISTRATION IN PATIENTS WITH ACUTE INTRACRANIAL VERTEBROBASILAR ARTERY OCCLUSION | 2008-09-16 | due-trials |
| Reported results | 2005-001171-36 | A Dose-Escalation Clinical Trial of Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy for Vitreomacular Traction Maculopathy | 2007-07-18 | due-trials |
| Reported results | 2006-004626-93 | A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding Trial of Microplasmin Intravitreal Injection for Non-Surgical PVD Induction for Treatment of Diabetic Macular... | 2010-05-17 | due-trials |
| Reported results | 2006-005731-16 | An Open Label Clinical Trial of Microplasmin Administered via the Trellis-8 Infusion System for the Treatment of Acute Iliofemoral Deep Vein Thrombosis | 2008-09-12 | due-trials |
| Completed, but no date, and reported results | 2006-006085-42 | A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding, Multicenter Trial of Microplasmin Intravitreal Injection for Non-Surgical PVD Induction for Treatment of Vit... | bad-data | |
| Reported results | 2008-004393-40 | A randomized, placebo controlled, double-masked, multicenter trial of microplasmin intravitreal injection for non-surgical treatment of focal vitreomacular adhesion. | 2010-06-15 | due-trials |
| Reported results | 2008-004539-39 | Single Intravenous Administration of TB-402 for the Prophylaxis of Venous hromboembolic Events (VTE) After Total Knee Replacement Surgery: A Dose-Escalating, Multicenter, Randomised, Active-Controlled... | 2010-01-22 | due-trials |
| Reported results | 2008-004844-35 | A Randomized, Sham-Injection Controlled, Double-Masked, Multicenter Trial of Microplasmin Intravitreal Injection for Treatment of Focal Vitreomacular Adhesion in Subjects with Exudative Age-Related Ma... | 2013-04-30 | due-trials |
| Completed, but no date, and reported results | 2008-005228-10 | An Open Label, Single Center Trial of Microplasmin Intravitreal Injection for Non-Surgical Treatment of Focal Vitreomacular Adhesion | bad-data | |
| Completed, but no date, and reported results | 2010-018919-16 | An Open-Label, Ascending- Exposure-Time, Single Center Trial to Evaluate the Pharmacokinetic Properties of Ocriplasmin (Generic Name of the Molecule Microplasmin) Intravitreal Injection in Subjects Sc... | bad-data | |
| Reported results | 2010-023383-40 | Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery: A Phase IIb, Multicentre, Randomised, Active-Controlled, Doub... | 2013-03-07 | due-trials |
| Reported results | 2015-002415-15 | A PHASE 2, RANDOMISED, DOUBLE-MASKED, SHAM-CONTROLLED, MULTI-CENTRE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OCRIPLASMIN IN INDUCING TOTAL POSTERIOR VITREOUS DETACHMENT (PVD) IN SUBJECTS WITH NON-... | 2019-11-18 | due-trials |
| Reported results | 2016-002100-25 | A Phase 2, single-masked, multicentre study to evaluate the safety and efficacy of 2 dose levels of THR-317 for the treatment of diabetic macular oedema (DME) | 2018-04-11 | due-trials |
| Reported results | 2017-003897-15 | A Phase 2, randomised, single-masked, active-controlled, multicentre study to evaluate the efficacy and safety of intravitreal THR-317 administered in combination with ranibizumab, for the treatment o... | 2019-07-18 | due-trials |
| Reported results | 2017-004010-26 | A Phase 2, open-label, multi-centre study to assess the efficacy and safety of intravitreal THR-317 for the treatment of macular telangiectasia Type 1 (MacTel 1) | 2019-11-22 | due-trials |